Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint and GeneLink to Develop Genetic Tests for Personalized Cosmetics

NEW YORK, March 7 - DNAPrint said yesterday that it will collaborate with GeneLink to develop genetic tests for personalized cosmetics.

 

Both companies intend to develop tests that would be used to assess the genetic risk for certain common skin deficiencies. Based on the test results, skin care products would be recommended that might compensate for these deficiencies. The tests would be offered as part of precautionary recommendations for certain dermatological and skin aging problems and offered to the cosmetics and personal care industry.

 

DNAPrint, based in Sarasota, Fla., will contribute its genotyping technology, while GeneLink will make use of existing tests and methods. Both companies intend to screen millions of candidate genetic markers.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.